计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
C111218-1g |
1g |
现货 ![]() |
| |
C111218-5g |
5g |
现货 ![]() |
| |
C111218-25g |
25g |
现货 ![]() |
| |
C111218-100g |
100g |
现货 ![]() |
|
别名 | 阿糖胞嘧啶 | 胞嘧啶 β-D-呋喃阿拉伯糖苷 | 4-氨基-1-β-D-阿拉伯呋喃糖基-2(1H)-嘧啶酮 |
---|---|
英文别名 | Cytosar | Cytosine 1-beta-D-arabinofuranoside | Ara-cell | Cytosine arabinoside (VAN) | Cytosine-1-beta-arabinofuranoside | Cytarabine (USAN:USP:INN:BAN:JAN) | CYTARABINE (USP MONOGRAPH) | UNII-04079A1RDZ | Iretin | 1-beta-D-Arabinosylcytosine | 1beta-D-A |
规格或纯度 | Moligand™, ≥98% |
英文名称 | Cytosine β-D-arabinofuranoside |
生化机理 | 嘧啶核苷类似物能够抑制DNA合成。在细胞周期的S期特别活跃。化学治疗剂。抗病毒和免疫抑制剂特性。 |
应用 | Ara-C 插入DNA,靠和拓扑异构酶I(topoisomerase I)形成络合物抑制DNA复制,导致DNA裂解。不能抑制RNA合成。 |
储存温度 | 2-8°C储存 |
运输条件 | 冰袋运输 |
作用类型 | 抑制剂 |
作用机制 | DNA 聚合酶(α/δ/epsilon)抑制剂 |
备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
产品介绍 |
溶于水,部分溶于甲醇,几乎不溶于乙醚,本品以D-阿拉伯糖或5′-胞嘧啶核苷酸为原料制得。常用其盐酸盐。 Ara-C 插入DNA,靠和拓扑异构酶I(topoisomerase I)形成络合物抑制DNA复制,导致DNA裂解。不能抑制RNA合成。 |
ALogP | -2.1 |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 488180029 |
---|---|
EC号 | 205-705-9 |
分子类型 | 小分子 |
IUPAC Name | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
INCHI | InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1 |
InChi Key | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
Canonical SMILES | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O |
Isomeric SMILES | C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O |
WGK Germany | 3 |
RTECS | HA5425000 |
PubChem CID | 6253 |
分子量 | 243.22 |
Beilstein号 | 89175 |
Reaxy-Rn | 89175 |
溶解性 | 可溶于水 |
---|---|
密度 | 1.89 |
比旋光度 | 158 ° (C=1, H2O) |
熔点 | 214°C |
分子量 | 243.220 g/mol |
XLogP3 | -2.100 |
氢键供体数Hydrogen Bond Donor Count | 4 |
氢键受体数Hydrogen Bond Acceptor Count | 5 |
可旋转键计数Rotatable Bond Count | 2 |
精确质量Exact Mass | 243.086 Da |
单同位素质量Monoisotopic Mass | 243.086 Da |
拓扑极表面积Topological Polar Surface Area | 129.000 Ų |
重原子数Heavy Atom Count | 17 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 383.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 4 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
象形图 | GHS08, GHS07 |
---|---|
信号词 | Danger |
危险声明 |
H317: 可能引起皮肤过敏反应 H360: 可能损害生育力或未出生的孩子 H340: 可能导致遗传缺陷 H361: 怀疑破坏生育力或未出生的孩子 |
预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302+P352: 如皮肤沾染:用水充分清洗。 P321: 特殊处理(请参阅此标签上的...)。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P281: 根据需要使用个人防护设备。 P272: 被污染的工作服不允许离开工作场所 P333+P313: 如发生皮肤刺激或皮疹:求医/就诊。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。 |
WGK Germany | 3 |
RTECS | HA5425000 |
Reaxy-Rn | 89175 |
Merck Index | 2784 |
个人防护装备 | Eyeshields,Faceshields,full-face particle respirator type N100 (US),Gloves,respirator cartridge type N100 (US),type P1 (EN143) respirator filter,type P3 (EN 143) respirator cartridges |
Specific Rotation [a]20/D(c=1 in H2O) | 155-162(°) |
---|---|
Purity(HPLC) | 98-100(%) |
Appearance(C111218) | White to Off-White Powder |
Proton NMR spectrum | Conforms to Structure |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
批号(Lot Number) | 证书类型 | 日期 | 货号 |
---|---|---|---|
![]() |
分析证书 | 24-04-02 | C111218 |
![]() |
分析证书 | 24-03-13 | C111218 |
![]() |
分析证书 | 23-01-09 | C111218 |
![]() |
分析证书 | 23-01-09 | C111218 |
![]() |
分析证书 | 23-01-09 | C111218 |
![]() |
分析证书 | 23-01-09 | C111218 |
![]() |
分析证书 | 23-01-09 | C111218 |
![]() |
分析证书 | 23-01-09 | C111218 |
![]() |
分析证书 | 23-01-09 | C111218 |
1. Qiankun Quan, Xinxin Ma, Ming Li, Xi Li, Haifeng Yuan. (2024) Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model. Experimental and Therapeutic Medicine, 27 (1): (1-13). [PMID:38125359] [10.3892/etm.2023.12319] |
2. Yue-Ming Yu, Fan-Zhi Bu, Su-Su Meng, Cui-Wei Yan, Zhi-Yong Wu, Yan-Tuan Li. (2023) The first nano-cocrystal formulation of marine drug cytarabine with uracil based on cocrystal nanonization strategy for long-acting injection exhibiting enhanced antitumor activity. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 644 (123300). [PMID:37567370] [10.1016/j.ijpharm.2023.123300] |
3. Lejiao Jia, Huatian Yang, Dandan Zheng, Jingjing Ye, Qian Zhou, Genjv Li, Ying Zhou, Xinyu Yang, Jinting Liu, Feng Ye, Yuliang Song, Daoxin Ma, Chunyan Ji. (2023) Smart and Generalizable Cytarabine Derivative-Triggered Nanoparticles for Synergistic Therapy of Relapsed/Refractory Acute Myeloid Leukemia. ACS Applied Materials & Interfaces, 15 (23): (27624–27637). [PMID:37249260] [10.1021/acsami.3c03632] |
4. Siyu Wang, Lutong Wang, Jingwen Xu, Yihai Wang, Limin Xiang, Xiangjiu He. (2023) Synergistic Combination of the Total Steroidal Saponins from the Berries of Black Nightshade and Adriamycin to Overcome Leukemia Multidrug Resistance. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 71 (7): (3315–3324). [PMID:36752041] [10.1021/acs.jafc.2c07740] |
5. Wang Pengwei, Mao Senlin, Yi Tingting, Wang Lihua. (2023) LncRNA MALAT1 Targets miR-9-3p to Upregulate SAP97 in the Hippocampus of Mice with Vascular Dementia. BIOCHEMICAL GENETICS, 61 (3): (916-930). [PMID:36227424] [10.1007/s10528-022-10289-2] |
6. Jie Zhao, Yue Wu, Shanshan Liang, Xiangyu Piao. (2022) Activation of SSAT1/ALOX15 Axis Aggravates Cerebral Ischemia/Reperfusion Injury via Triggering Neuronal Ferroptosis. NEUROSCIENCE, 485 (78). [PMID:35090880] [10.1016/j.neuroscience.2022.01.017] |
7. Dan Shao, Qiang Gao, Yanshan Sheng, Shangji Li, Yong Kong. (2022) Construction of a dual-responsive dual-drug delivery platform based on the hybrids of mesoporous silica, sodium hyaluronate, chitosan and oxidized sodium carboxymethyl cellulose. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 202 (37). [PMID:35033530] [10.1016/j.ijbiomac.2022.01.033] |
8. Lefeng Liu, Zhiguo Xu, Yang Liu, Zheng-Zhi Yin, Yanshan Sheng, Chengqiang Ding, Yong Kong. (2021) Facile synthesis of calcium carbonate/polyacrylic acid hydrogels for pH-responsive delivery of cytarabine. Journal of Saudi Chemical Society, 25 (101344). [10.1016/j.jscs.2021.101344] |
9. Yuzhe Chen, Wenxuan Zhao, Honglian Dai. (2021) Porous PLGA-PEG nerve conduit decorated with oriented electrospun chitosan-RGD nanofibre. Journal of Materials Research and Technology-JMR&T, 15 (86). [10.1016/j.jmrt.2021.07.117] |
10. Kai Chen, Yong Qian, Chaoyang Wang, Dongjie Yang, Xueqing Qiu, Bernard P. Binks. (2021) Tumor microenvironment-responsive, high internal phase Pickering emulsions stabilized by lignin/chitosan oligosaccharide particles for synergistic cancer therapy. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 591 (352). [PMID:33618293] [10.1016/j.jcis.2021.02.012] |
11. Qiang Gao, Jun Gao, Chengqiang Ding, Shangji Li, Linhong Deng, Yong Kong. (2021) Construction of a pH- and near-infrared irradiation-responsive nanoplatform for chemo-photothermal therapy. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 593 (120112). [PMID:33259903] [10.1016/j.ijpharm.2020.120112] |
12. Yanshan Sheng, Wei Dai, Jun Gao, Hongda Li, Wensheng Tan, Jingwei Wang, Linhong Deng, Yong Kong. (2020) pH-sensitive drug delivery based on chitosan wrapped graphene quantum dots with enhanced fluorescent stability. Materials Science & Engineering C-Materials for Biological Applications, 112 (110888). [PMID:32409046] [10.1016/j.msec.2020.110888] |
13. Zhigang Fang, Xiaozhen Wang, Yanling Sun, Ruifang Fan, Zhong Liu, Rui Guo, Deming Xie. (2019) Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia. Nanoscale, 11 (47): (23000-23012). [PMID:31769777] [10.1039/C9NR07391D] |
14. Jing Liu, Dujuan Zhao, Wenxiu He, Huiyuan Zhang, Zhonghao Li, Yuxia Luan. (2017) Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 487 (239). [PMID:27776282] [10.1016/j.jcis.2016.10.041] |
15. Jing Liu, Jing Liu, Dujuan Zhao, Naxin Ma, Yuxia Luan. (2016) Highly enhanced leukemia therapy and oral bioavailability from a novel amphiphilic prodrug of cytarabine. RSC Advances, 6 (42): (35991-35999). [10.1039/C6RA02051H] |
16. Yadong Tang,Boxin Huang,Yuqin Dong,Wenlong Wang,Xi Zheng,Wei Zhou,Kun Zhang,Zhiyun Du. (2017-06-07) Three-dimensional prostate tumor model based on a hyaluronic acid-alginate hydrogel for evaluation of anti-cancer drug efficacy.. Journal of biomaterials science. Polymer edition, 28 ((14)): (1603-1616). [PMID:28583017] |
1. Lautenschläger J et al.. (2018) An Easy-to-Implement Protocol for Preparing Postnatal Ventral Mesencephalic Cultures.. Front Cell Neurosci, 12 (44). [PMID:29556177] |
2. Qiankun Quan, Xinxin Ma, Ming Li, Xi Li, Haifeng Yuan. (2024) Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model. Experimental and Therapeutic Medicine, 27 (1): (1-13). [PMID:38125359] [10.3892/etm.2023.12319] |
3. Yue-Ming Yu, Fan-Zhi Bu, Su-Su Meng, Cui-Wei Yan, Zhi-Yong Wu, Yan-Tuan Li. (2023) The first nano-cocrystal formulation of marine drug cytarabine with uracil based on cocrystal nanonization strategy for long-acting injection exhibiting enhanced antitumor activity. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 644 (123300). [PMID:37567370] [10.1016/j.ijpharm.2023.123300] |
4. Lejiao Jia, Huatian Yang, Dandan Zheng, Jingjing Ye, Qian Zhou, Genjv Li, Ying Zhou, Xinyu Yang, Jinting Liu, Feng Ye, Yuliang Song, Daoxin Ma, Chunyan Ji. (2023) Smart and Generalizable Cytarabine Derivative-Triggered Nanoparticles for Synergistic Therapy of Relapsed/Refractory Acute Myeloid Leukemia. ACS Applied Materials & Interfaces, 15 (23): (27624–27637). [PMID:37249260] [10.1021/acsami.3c03632] |
5. Siyu Wang, Lutong Wang, Jingwen Xu, Yihai Wang, Limin Xiang, Xiangjiu He. (2023) Synergistic Combination of the Total Steroidal Saponins from the Berries of Black Nightshade and Adriamycin to Overcome Leukemia Multidrug Resistance. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 71 (7): (3315–3324). [PMID:36752041] [10.1021/acs.jafc.2c07740] |
6. Wang Pengwei, Mao Senlin, Yi Tingting, Wang Lihua. (2023) LncRNA MALAT1 Targets miR-9-3p to Upregulate SAP97 in the Hippocampus of Mice with Vascular Dementia. BIOCHEMICAL GENETICS, 61 (3): (916-930). [PMID:36227424] [10.1007/s10528-022-10289-2] |
7. Jie Zhao, Yue Wu, Shanshan Liang, Xiangyu Piao. (2022) Activation of SSAT1/ALOX15 Axis Aggravates Cerebral Ischemia/Reperfusion Injury via Triggering Neuronal Ferroptosis. NEUROSCIENCE, 485 (78). [PMID:35090880] [10.1016/j.neuroscience.2022.01.017] |
8. Dan Shao, Qiang Gao, Yanshan Sheng, Shangji Li, Yong Kong. (2022) Construction of a dual-responsive dual-drug delivery platform based on the hybrids of mesoporous silica, sodium hyaluronate, chitosan and oxidized sodium carboxymethyl cellulose. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 202 (37). [PMID:35033530] [10.1016/j.ijbiomac.2022.01.033] |
9. Lefeng Liu, Zhiguo Xu, Yang Liu, Zheng-Zhi Yin, Yanshan Sheng, Chengqiang Ding, Yong Kong. (2021) Facile synthesis of calcium carbonate/polyacrylic acid hydrogels for pH-responsive delivery of cytarabine. Journal of Saudi Chemical Society, 25 (101344). [10.1016/j.jscs.2021.101344] |
10. Yuzhe Chen, Wenxuan Zhao, Honglian Dai. (2021) Porous PLGA-PEG nerve conduit decorated with oriented electrospun chitosan-RGD nanofibre. Journal of Materials Research and Technology-JMR&T, 15 (86). [10.1016/j.jmrt.2021.07.117] |
11. Kai Chen, Yong Qian, Chaoyang Wang, Dongjie Yang, Xueqing Qiu, Bernard P. Binks. (2021) Tumor microenvironment-responsive, high internal phase Pickering emulsions stabilized by lignin/chitosan oligosaccharide particles for synergistic cancer therapy. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 591 (352). [PMID:33618293] [10.1016/j.jcis.2021.02.012] |
12. Qiang Gao, Jun Gao, Chengqiang Ding, Shangji Li, Linhong Deng, Yong Kong. (2021) Construction of a pH- and near-infrared irradiation-responsive nanoplatform for chemo-photothermal therapy. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 593 (120112). [PMID:33259903] [10.1016/j.ijpharm.2020.120112] |
13. Yanshan Sheng, Wei Dai, Jun Gao, Hongda Li, Wensheng Tan, Jingwei Wang, Linhong Deng, Yong Kong. (2020) pH-sensitive drug delivery based on chitosan wrapped graphene quantum dots with enhanced fluorescent stability. Materials Science & Engineering C-Materials for Biological Applications, 112 (110888). [PMID:32409046] [10.1016/j.msec.2020.110888] |
14. Zhigang Fang, Xiaozhen Wang, Yanling Sun, Ruifang Fan, Zhong Liu, Rui Guo, Deming Xie. (2019) Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia. Nanoscale, 11 (47): (23000-23012). [PMID:31769777] [10.1039/C9NR07391D] |
15. Jing Liu, Dujuan Zhao, Wenxiu He, Huiyuan Zhang, Zhonghao Li, Yuxia Luan. (2017) Nanoassemblies from amphiphilic cytarabine prodrug for leukemia targeted therapy. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 487 (239). [PMID:27776282] [10.1016/j.jcis.2016.10.041] |
16. Jing Liu, Jing Liu, Dujuan Zhao, Naxin Ma, Yuxia Luan. (2016) Highly enhanced leukemia therapy and oral bioavailability from a novel amphiphilic prodrug of cytarabine. RSC Advances, 6 (42): (35991-35999). [10.1039/C6RA02051H] |
17. Yadong Tang,Boxin Huang,Yuqin Dong,Wenlong Wang,Xi Zheng,Wei Zhou,Kun Zhang,Zhiyun Du. (2017-06-07) Three-dimensional prostate tumor model based on a hyaluronic acid-alginate hydrogel for evaluation of anti-cancer drug efficacy.. Journal of biomaterials science. Polymer edition, 28 ((14)): (1603-1616). [PMID:28583017] |